Concepedia

Eckhart Kaempgen

EK

Statistics

Publications

16

Citations

4.3K

H-Index

14

Active since

2004

Affiliations

Universitätsklinikum Erlangen(Current)

Hôpital Saint-André

Friedrich-Alexander-Universität Erlangen-Nürnberg

The Maria Sklodowska-Curie National Research Institute of Oncology

Charité - Universitätsmedizin Berlin

Eckhart Kaempgen is an author at Universitätsklinikum Erlangen specializing in medicine, radiation oncology, and oncology.

Top concepts

Publications per year

2004–2017

16

Publications

16

Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial

Axel Hauschild, Jean‐Jacques Grob, Lev Demidov et al. · The Lancet · 2012 · 2.9K citations

, , +6

Postoperative Adjuvant Dendritic Cell–Based Immunotherapy in Patients with Relapsed Glioblastoma Multiforme

Steven De Vleeschouwer, Steffen Fieuws, Stefan Rutkowski et al. · Clinical Cancer Research · 2008 · 268 citations · Full text

Surgery and adjuvant dendritic cell-based tumour vaccination for patients with relapsed malignant glioma, a feasibility study

Stefan Rutkowski, Steven De Vleeschouwer, Eckhart Kaempgen et al. · British Journal of Cancer · 2004 · 171 citations · Full text

Hepatic intra-arterial versus intravenous fotemustine in patients with liver metastases from uveal melanoma (EORTC 18021): a multicentric randomized trial

Serge Leyvraz, Sophie Piperno‐Neumann, Stefan Suciu et al. · Annals of Oncology · 2014 · 142 citations · Full text

, , +12

Immunologic response to the survivin-derived multi-epitope vaccine EMD640744 in patients with advanced solid tumors

Volker Lennerz, Elisa Gallerani, Cristiana Sessa et al. · Cancer Immunology Immunotherapy · 2014 · 125 citations · Full text

, , +11

1–5 of 16